BAYZF News and Press, Bayer AG Registered Shares From 02/26/26

Final results for the key secondary endpoint of overall survival (OS) from the PEACE-3 trial will be presented by the European Organization for Research and Treatment of Cancer (EORTC) coalition as an oral abstract at ASCO GU 2026. XOFIGO ® (radium-223 dichloride) in combination with...

Bayer files false advertising suit against J&J and Janssen Biotech Lawsuit seeks preliminary and permanent injunctions in addition to damages. This flawed J&J data analysis conveys false information to patients and healthcare providers; Superiority claims of ERLEADA® are ...

2026-02-22 17:01:54 ET US stock indexes ended the week higher amid a U.S. military buildup in the Middle East, earnings results and expectations that the Federal Reserve will maintain rates elevated for a longer period. ... Read the full article on Seeking Alpha For further...

2026-02-18 09:07:02 ET More on Bayer Bayer Discusses Roundup Class Settlement Agreement and Implications for U.S. Glyphosate Litigation Transcript Bayer: Timing Upside In 2025, More Upside Possible But Risky In 2026E (Downgrade) Bayer: Is This The Turning Point Inves...

2026-02-17 18:34:56 ET Bayer Aktiengesellschaft (BAYRY) Discusses Roundup Class Settlement Agreement and Implications for U.S. Glyphosate Litigation February 17, 2026 12:30 PM EST... Read the full article on Seeking Alpha For further details see: Bayer Aktiengesellschaft (BA...

2026-02-17 11:12:41 ET More on Bayer Bayer Discusses OCEANIC-STROKE Phase III Results and Asundexian in Secondary Stroke Prevention - Slideshow Bayer: Timing Upside In 2025, More Upside Possible But Risky In 2026E (Downgrade) Bayer: Is This The Turning Point Investor...

2026-02-17 08:25:08 ET More on Ocular Therapeutix Ocular Therapeutix: Considering Their Phase 3 'Superiority' Trial's Prospect Ocular Therapeutix: Why SOL-1 Trial Outcome Is Likely Positive Why Sanofi May Need To Top $2.4 Billion For Ocular Therapeutix Ocular...

This February, the brand continues its See Your Risks initiative by challenging denial and bringing unseen heart health risk factors into view. This American Heart Month, Bayer ® Aspirin continues its mission to help people uncover the heart health risk factors they may not...

2026-02-09 11:50:47 ET More on Corteva Corteva, Inc. (CTVA) Q4 2025 Earnings Call Transcript Corteva, Inc. 2025 Q4 - Results - Earnings Call Presentation Corteva: Get Your Piece Of SpinCo As A Stable Portfolio Compounder Corteva downgraded at J.P. Morgan on v...

2026-02-06 12:24:20 ET Bayer Aktiengesellschaft (BAYRY) Discusses OCEANIC-STROKE Phase III Results and Asundexian in Secondary Stroke Prevention February 6, 2026 9:00 AM EST... Read the full article on Seeking Alpha For further details see: Bayer Aktiengesellschaft (BAYRY) D...